Cytek Biosciences, Inc. (CTKB) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -2.74M | -771K | -3.9M | 108K | -125K | 2M | 13.22M | 6.2M | 3.96M | 9.51M | -4.24M | -2.85M | 2.86M | 6.19M | -7.5M | -9.44M | -1.48M | 5.45M | 1.16M | -3.91M |
| Operating CF Margin % | -6.2% | -1.24% | -7.45% | 0.24% | -0.3% | 3.47% | 25.67% | 13.31% | 8.82% | 16.33% | -8.83% | -5.74% | 7.71% | 12.81% | -18.54% | -23.51% | -4.22% | 14.01% | 3.38% | -12.87% |
| Operating CF Growth % | -2088.8% | -138.61% | -129.48% | -98.26% | -103.16% | -79.01% | 411.89% | 317.68% | 38.45% | 53.59% | 43.51% | 69.81% | 293.11% | 13.67% | -746.34% | -141.19% | -176.49% | -53.2% | - | - |
| Net Income | -18.87M | -44.08M | -5.48M | -5.58M | -11.4M | 9.64M | 940K | -10.43M | -6.17M | 5.5M | -6.46M | -4.39M | -6.81M | 3.72M | 1.67M | -598K | -2.16M | -1.17M | 346K | 0 |
| Depreciation & Amortization | 2.81M | 3.04M | 3.06M | 2.99M | 2.88M | 2.74M | 2.81M | 2.48M | 2.46M | 2.42M | 2.56M | 2.44M | 1.8M | 1.86M | 771K | 866K | 1.47M | 685K | 194K | 200K |
| Stock-Based Compensation | 4.86M | 5.53M | 5.64M | 6.79M | 6.63M | 7M | 7.05M | 7.15M | 5.64M | 5.67M | 5.76M | 5.92M | 4.7M | 4.46M | 4.36M | 0 | 3.84M | 3.01M | 0 | 0 |
| Deferred Taxes | -183K | 38.58M | -2.63M | -2.06M | -336K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -359K | -366K | -928K | -1.25M | -930K | -11.89M | 12.37M | -1.1M | 179K | -246K | -831K | -1.74M | -272K | 886K | 1.69M | 5.28M | 572K | 913K | 4.03M | 3.68M |
| Working Capital Changes | 9M | -3.48M | -3.56M | -785K | 3.03M | -5.5M | -9.95M | 8.11M | 1.85M | -3.84M | -5.27M | -5.09M | 3.44M | -4.74M | -15.99M | -14.99M | -5.2M | 2.01M | -3.41M | -7.8M |
| Change in Receivables | 9.64M | -6.15M | -587K | 652K | 6.45M | -9.33M | -6.25M | 5.92M | 4.24M | 263K | -6.85M | -6.8M | 6.05M | -7.96M | -3.82M | -6.93M | -1.04M | -720K | -5.59M | -8.29M |
| Change in Inventory | -1.63M | 2.05M | -2.22M | -3.57M | -1.5M | 2M | 3.56M | 4.43M | 4.77M | 6.33M | -1.89M | 3.03M | -3.19M | 1.88M | -5.18M | -8.43M | -5.92M | -2.23M | -964K | -260K |
| Change in Payables | 390K | -1.31M | 588K | 759K | 410K | 258K | 2.23M | -519K | 615K | -1.79M | 1.71M | -2M | 0 | -908K | 0 | 895K | 2.78M | -742K | 635K | -261K |
| Cash from Investing | -27.08M | -1.84M | 18.92M | -16.41M | 9.45M | -63.43M | -15.81M | 2.02M | -5.75M | 29.07M | 43.12M | 2.79M | -168.87M | -51.06M | -1.15M | -2.92M | -780K | -18.3M | -1.31M | -1.25M |
| Capital Expenditures | -2.17M | -1M | -657K | -1.58M | -849K | -894K | -808K | -1.05M | -567K | -1.5M | -1.33M | -1.31M | -505K | -6.53M | -1.11M | -1.33M | -780K | -1.3M | -1.31M | -1.25M |
| CapEx % of Revenue | 4.91% | 1.61% | 1.26% | 3.46% | 2.05% | 1.56% | 1.57% | 2.26% | 1.26% | 2.58% | 2.77% | 2.64% | 1.36% | 13.51% | 2.74% | 3.31% | 2.22% | 3.33% | 3.81% | 4.11% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | -471K | -76K | 0 | 0 | -1K | -1K | 0 | -44.9M | 0 | 0 | 0 | 0 | -17M | 371K | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -27K | 162K | 1K | -49K | 31K | 182K | -98K | -72K | -55K | -61K | -63K | -55K | -123.47M | -80K | -40K | 0 | 0 | 0 | -371K | 0 |
| Cash from Financing | 3.98M | -1.23M | 1.94M | -2.6M | -11.54M | -3.64M | -12.08M | -1.71M | 1.61M | -33.75M | -8.27M | 216K | 0 | 3.85M | 155K | 1.14M | 364K | 17K | 217.08M | -3.72M |
| Debt Issued (Net) | 4.2M | -1.52M | 1.95M | 1.24M | -828K | 2.65M | -135K | -142K | 1.25M | -140K | -138K | -141K | -146K | -50K | 0 | 0 | 0 | 0 | 0 | -2.77M |
| Equity Issued (Net) | 21K | 565K | 29K | -3.74M | -10.63M | -6.99M | -11.95M | -2.67M | 0 | -34.74M | -8.43M | 0 | -57K | 1.18M | -71K | 446K | 0 | 0 | 217.08M | -951K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 34K | 29K | -4.51M | -10.63M | -6.99M | -11.95M | -2.67M | 0 | -34.74M | -8.43M | 0 | -57K | 0 | -71K | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -239K | -267K | -34K | -102K | -90K | 705K | 1K | 1.1M | 358K | 1.13M | 292K | 357K | 203K | 2.72M | 226K | 698K | 364K | 17K | 0 | 0 |
| Net Change in Cash | -25.19M | -2.43M | 17.81M | -19.83M | -3.45M | -63.56M | -15.62M | 8.78M | 1.51M | 4M | 32.09M | -850K | -167.11M | -42.02M | -8.37M | -12.61M | -2.11M | -12.15M | 216.93M | -8.74M |
| Free Cash Flow | -4.9M | -1.77M | -4.55M | -1.47M | -976K | 1.09M | 12.41M | 5M | 3.33M | 7.95M | -5.63M | -4.22M | 2.35M | -417K | -8.61M | -10.77M | -2.26M | 4.15M | -147K | -5.17M |
| FCF Margin % | -11.11% | -2.85% | -8.71% | -3.22% | -2.35% | 1.9% | 24.1% | 10.73% | 7.43% | 13.65% | -11.73% | -8.49% | 6.34% | -0.86% | -21.28% | -26.81% | -6.45% | 10.68% | -0.43% | -16.99% |
| FCF Growth % | -402.46% | -261.97% | -136.68% | -129.36% | -129.27% | -86.24% | 320.4% | 218.61% | 41.73% | 2006.71% | 34.62% | 60.83% | 204.12% | -110.04% | -5759.86% | -108.48% | -258.49% | -63.7% | - | - |
| FCF per Share | -0.04 | -0.01 | -0.04 | -0.01 | -0.01 | 0.01 | 0.09 | 0.04 | 0.03 | 0.06 | -0.04 | -0.03 | 0.02 | -0.00 | -0.06 | -0.08 | -0.02 | 0.04 | -0.00 | -0.04 |
| FCF Conversion (FCF/Net Income) | 0.15x | 0.02x | 0.71x | -0.02x | 0.01x | 0.21x | 14.05x | -0.59x | -0.64x | 1.73x | 0.66x | 0.65x | -0.42x | 1.75x | -4.50x | 15.79x | 0.73x | -4.57x | 0.82x | -1.47x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 25K | 0 | 1.91M | 864K | 1.06M | 0 | 4.5M | 127K | 590K | 0 | 460K | 0 | 0 | 75K | 625K | 0 | 0 |